MoneyWorks4Me

Novartis - Quaterly Results

08 Feb 2023 Evaluate
Net sales declined -18.99%  to  Rs. 801.70 million from Rs. 989.60 millions.A humble growth in net profit of 19.84% reported in the quarter ended December 2022 to Rs. 76.10  millions from Rs. 63.50 millions.Operating profit surged to 160.00 millions from the corresponding previous quarter of 126.00 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 801.70 989.60 -18.99 3026.10 3015.50 0.35 3998.70 3813.50 4.86
Other Income 83.60 60.40 38.41 417.40 188.80 121.08 331.90 330.90 0.30
PBIDT 160.00 126.00 26.98 975.00 403.70 141.52 603.00 598.80 0.70
Interest 4.60 14.60 -68.49 14.50 45.00 -67.78 48.30 76.80 -37.11
PBDT 155.40 111.40 39.50 960.50 358.70 167.77 58.30 522.00 -88.83
Depreciation 13.00 27.50 -52.73 39.80 83.40 -52.28 96.50 121.60 -20.64
PBT 142.40 83.90 69.73 920.70 275.30 234.44 -38.20 400.40 -109.54
TAX 66.30 20.40 225.00 137.30 78.80 74.24 -1.00 191.40 -100.52
Deferred Tax 15.40 -4.90 -414.29 50.70 -17.60 -388.07 3.40 -34.80 -109.77
PAT 76.10 63.50 19.84 783.40 196.50 298.68 -37.20 209.00 -117.80
Equity 123.40 123.40 0.00 123.40 123.40 0.00 123.40 123.40 0.00
PBIDTM(%) 19.96 12.73 56.75 32.22 13.39 140.67 15.08 15.70 -3.96
Peers